×
About 3,805 results

ALLMedicine™ Atrioventricular Block Center

Research & Reviews  1,283 results

Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant f...
https://doi.org/10.1177/03331024221137092
Cephalalgia : an International Journal of Headache; Begasse de Dhaem O, Takizawa T et. al.

Feb 6th, 2023 - Long-term data helps assess the consistency of efficacy, tolerability, and safety of acute treatment over repeated use for different attacks. Real-world studies help assess tolerability, safety, and efficacy in patients with possibly refractory ch...

Elevated Random Glucose Levels at Admission are Associated with All-cause Mortality and...
https://doi.org/10.1002/dmrr.3617
Diabetes/metabolism Research and Reviews; Yuan Y, Tao J et. al.

Feb 3rd, 2023 - Elevated glucose levels at admission are associated with a worse prognosis in patients with acute myocardial infarction (AMI); additionally, such elevation has a higher prognostic value for patients without diabetes mellitus (DM). We retrospective...

Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular C...
https://doi.org/10.1161/CIRCULATIONAHA.122.062124
Circulation Friedman DJ, Al-Khatib SM et. al.

Jan 27th, 2023 - Benefit from cardiac resynchronization therapy (CRT) varies by QRS characteristics; individual randomized trials are underpowered to assess benefit for relatively small subgroups. The authors analyzed patient-level data from pivotal CRT trials (MI...

Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation
https://clinicaltrials.gov/ct2/show/NCT05699044

Jan 26th, 2023 - The investigators will nationally investigate the prevalence of Transthyretin Amyloidosis wildtype (ATTRwt) in patients of ≥ 65 years with either left ventricular hypertrophy and/or other red flags for Cardiac Amyloidosis who present with high deg...

Atrioventricular Block and Cluster Headache (SEVA)
https://clinicaltrials.gov/ct2/show/NCT04406259

Jan 25th, 2023 - Verapamil is a calcium channel blocker widely used to treat cardiovascular diseases however it is also the first line treatment in the prevention of cluster headaches. In France, its prescription in that indication is based on compliance with the ...

see more →

Drugs  63 results see all →

Clinicaltrials.gov  73 results

Screening of ATTRwt in Patient With Advanced AV-Block Undergoing Pacemaker Implantation
https://clinicaltrials.gov/ct2/show/NCT05699044

Jan 26th, 2023 - The investigators will nationally investigate the prevalence of Transthyretin Amyloidosis wildtype (ATTRwt) in patients of ≥ 65 years with either left ventricular hypertrophy and/or other red flags for Cardiac Amyloidosis who present with high deg...

Atrioventricular Block and Cluster Headache (SEVA)
https://clinicaltrials.gov/ct2/show/NCT04406259

Jan 25th, 2023 - Verapamil is a calcium channel blocker widely used to treat cardiovascular diseases however it is also the first line treatment in the prevention of cluster headaches. In France, its prescription in that indication is based on compliance with the ...

Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
https://clinicaltrials.gov/ct2/show/NCT04474223

Jan 11th, 2023 - Fetal complete (3°) atrioventricular block (AVB), identified in the 2nd trimester in an otherwise normally developing heart, is almost universally associated with maternal anti-Ro autoantibodies, which transcytose the placenta via the trophoblasti...

Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening.
https://clinicaltrials.gov/ct2/show/NCT04300985

Jan 11th, 2023 - INTRODUCTION Magnesium sulfate (MS) and dexmedetomidine have already demonstrated the ability to reduce intra and postoperative consumption of anesthetics and analgesics, among others advantages, such as blood pressure control and intraoperative b...

Pulmonary Artery Pressure and Right Heart Evaluation for Patients Requiring Physiological Pacing Treatment
https://clinicaltrials.gov/ct2/show/NCT05575557

Dec 29th, 2022 - This study was designed to investigate the acute and chronic effect of different pacing methods on the function of pulmonary artery and right heart. Studied population: The investigated population are patients eligible for pacemaker implantation a...

see more →

News  103 results

ESC Updates Guidelines for Ventricular Arrhythmia, Sudden Death
https://www.medscape.com/viewarticle/980972

Sep 16th, 2022 - New European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death contain a variety of updates since the 2015 edition — including 140 new recommendations and ...

Aggressive Alcohol Septal Ablation for HCM Holds Up, Pacemakers Notwithstanding
https://www.medpagetoday.com/cardiology/chf/100711

Sep 14th, 2022 - The occurrence of high-grade conduction disturbances after alcohol septal ablation (ASA) did not translate into worse long-term survival for people with obstructive hypertrophic cardiomyopathy (HCM), a registry study showed. Among ASA procedures i...

Ibrutinib/Rituximab Combo Represents Effective Chemo-Free Option for Elderly Patients with MCL
https://www.onclive.com/view/ibrutinib-rituximab-combo-represents-effective-chemo-free-option-for-elderly-patients-with-mcl

Jan 14th, 2022 - The combination of ibrutinib (Imbruvica) and rituximab (Rituxan) produced a high overall response rate (ORR) and durable survival in elderly patients with mantle cell lymphoma (MCL), according to data from a phase 2 ENRICH trial (NCT0180567) publi...

COVID-19 Tied to a Wide Range of ECG Findings
https://www.medscape.com/viewarticle/962691

Nov 11th, 2021 - NEW YORK (Reuters Health) - It's now clear that COVID-19 infection, while largely a respiratory illness, has a number of cardiac manifestations that include myocardial infarction, myocarditis and various patterns of changes observed on electrocard...

One Aducanumab Patient, Six Brain Edema Episodes
https://www.medpagetoday.com/neurology/alzheimersdisease/95523

Nov 8th, 2021 - A man treated with the recently approved Alzheimer's drug aducanumab (Aduhelm) had six amyloid-related imaging abnormality (ARIA) episodes, researchers reported. Over 44 months in a long-term extension study, the Alzheimer's disease patient had re...

see more →